, Tracking Stock Market Picks
Enter Symbol:
Rating: HOLX
Equal Weight $40
down 44.00 %

Hologic, Inc. (NASDAQ: HOLX) reiterated to Equal Weight with price target $40 by Barclays

Wednesday,  Sep 2, 2015  1:25 PM ET by Betsy O'Brien Harrison

Barclays reiterated Hologic, Inc. (NASDAQ: HOLX) to Equal Weight with price target $40. Previously Barclays reiterated Hologic, Inc. (NASDAQ: HOLX) to Underweight with price
target $24 on 01/07/2015, when the stock price was $25.90. Since then, Hologic, Inc.'s stock price has gained 44% as of 09/02/2015's recent price of $37.38.
If you would have followed the previous Barclays's recommendation on HOLX, you would have lost 44% of your investment in 238 days.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.


RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy